Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial

导出原文传递

翻译打印收藏纠错

作者： Ogata, Hiroaki ^[1] ; Fukagawa, Masafumi ^[2] ; Hirakata, Hideki ^[3] ; Kagimura, Tatsuo ^[4] ; Fukushima, Masanori ^[5] ; Akizawa, Tadao

作者单位： Fukuoka Renal Clin, Chuo Ku, Fukuoka, Japan ^[1] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Div Nephrol,Tsuzuki Ku, Chigasaki Chuo 35-1 ^[2] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa, Japan ^[3] Fdn Biomed Res & Innovat Kobe, Translat Res Ctr Med Innovat, Chuo Ku, Kobe, Hyogo, Japan ^[4] Showa Univ, Sch Med, Dept Med, Div Nephrol,Shinagawa Ku, Tokyo, Japan ^[5]

发布时间 2021-07-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA

2021年325卷19期

1946-1954页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial

JAMA

相似文献

JAMA

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial

JAMA

相似文献

JAMA

相关期刊

检索历史清除